Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Plan B Language To Be Included In Conference Report On FDA Appropriations

This article was originally published in The Pink Sheet Daily

Executive Summary

Sen. Murray withdrew four amendments to the Ag Approps bill in exchange for a pledge that language will appear in the report expressing bipartisan concern over the emergency contraceptive’s review process.

You may also be interested in...



Senators Request Probe Of FDA Conflict of Interest Waivers

Increasing concern over FDA advisory committee members’ conflicts of interest prompts Senators Enzi, Kennedy and Durbin to seek assistance from the Government Accountability Office in conducting a review of the policy.

FDA Approps Bill Debate Could Include “Controversial Amendments,” Sen. Hatch Says

Amendments on drug importation, Plan B and follow-on biologics could be brought to the Senate floor during debate on the Agriculture appropriations measure.

Barr’s Expanded Thalidomide ANDA Could Increase Likelihood Of A Marketed Generic

Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.

Topics

UsernamePublicRestriction

Register

PS062935

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel